SCHEMBL6726432

SCHEMBL6726432

O=C(O)c1c[nH]c2ccc(OCCCN3CCCCC3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.49
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.46
ALDH1A1 P00352 6/20 0.44
PARP1 P09874 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
THPO P40225 1/20 0.44
KDM4E B2RXH2 5/20 0.44
HRH3 Q9Y5N1 2/20 0.44
KCNH2 Q12809 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
PMP22 Q01453 1/20 0.43
MEN1 O00255 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
ABCB1 P08183 1/20 0.43
PRKAB2 O43741 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6726280 0.97 DHODH (0.46) DHODHMAPTPOLBALDH1A1PARP1
SCHEMBL6724501 0.93 ALDH1A1 (0.46) DHODHALDH1A1PARP1CYP1A2CYP2D6
SCHEMBL6724740 0.90 PRKAB2 (0.52) DHODHMAPTPOLBALDH1A1KDM4E
SCHEMBL6726264 0.89 PRKAB2 (0.53) DHODHMAPTPOLBALDH1A1KDM4E
SCHEMBL6726653 0.86 KDM4E (0.52) ALDH1A1KDM4EHRH3SMN1; SMN2
SCHEMBL6724521 0.84 PRKAB2 (0.46) MAPTPOLBALDH1A1KDM4EMEN1
SCHEMBL6722255 0.83 PRKAB2 (0.52) DHODHMAPTPOLBALDH1A1TSHR
SCHEMBL6733358 0.83 PRKAB2 (0.37) DHODHMAPTALDH1A1CYP1A2CYP2C9
SCHEMBL6724794 0.82 MET (0.53) MAPTPOLBALDH1A1PARP1CYP1A2
SCHEMBL6734639 0.79 HRH3 (0.41) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed